- ¥309bn
- ¥327bn
- ¥150bn
- 94
- 41
- 94
- 91
Annual cashflow statement for Organo, fiscal year end - March 31st, JPY millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 9,850 | 9,695 | 12,696 | 16,035 | 23,633 |
| Depreciation | |||||
| Non-Cash Items | 427 | 106 | -1,203 | 270 | 713 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -2,915 | -15,595 | -1,724 | -36,665 | -22,631 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 8,551 | -4,582 | 11,101 | -18,536 | 3,725 |
| Capital Expenditures | -968 | -1,254 | -2,798 | -1,452 | -1,647 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -38 | -7 | 1,278 | 143 | 232 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -1,006 | -1,261 | -1,520 | -1,309 | -1,415 |
| Financing Cash Flow Items | -36 | -29 | -112 | -181 | -210 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -5,007 | 4,927 | -2,586 | 14,706 | -641 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 2,495 | -968 | 7,393 | -4,639 | 2,084 |